- Elanco Animal Health announced the FDA approved Zenrelia™, a once-daily oral JAK inhibitor for control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. The approval enters Elanco into the estimated $1.7 billion global canine dermatology market.
- So far this year, just more than $500 million has gone to roughly 50 pet- and vet-care-related startups globally, per Crunchbase data. That puts 2024 on track for the lowest investment in years. But there were exceptions, e.g., Loyal, which develops medicines to extend dogs’ healthy lifespans, Sploot Veterinary Care, which offers primary and urgent care for pets, and MoeGo, a platform for pet groomers and other care providers to manage their services.
- Antelligence, publisher of Fountain Report, launches the first-ever comprehensive database of over 8,800 corporate veterinary practice locations across the U.S. Available via annual subscription with quarterly updates, this database also includes advanced insights into the corporate veterinary landscape for deeper analysis.